CLINICAL NEUROPHYSIOLOGY, cilt.115, ss.1417-1422, 2004 (SCI İndekslerine Giren Dergi)
Objective: Succinic semialdehyde dehydrogenase (SSADH) deficiency is a neurometabolic disorder characterized by excessive GABA levels and seizures. There has been no clinical phenotype described to date with heterozygosity for SSADH deficiency.